Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy (UNIFLECA)
UNIFLECA Study: Prospective Cohort Study on Flecainide's Impact on Persistent High Premature Ventricular Contraction Burden and PVC-Induced Cardiomyopathy
Sponsor: Aristotle University Of Thessaloniki
Listed as NCT06949748, this observational or N/A phase trial focuses on Arrhythmia Ventricular and Cardiomyopathies and remains actively recruiting participants. Sponsored by Aristotle University Of Thessaloniki, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
-
May 2025 — Aug 2025 [monthly]
Recruiting
First recorded
Apr 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aristotle University Of Thessaloniki
- Institute for Study, Research, Education and Therapy of Vascular, Heart, Brain and Kidney Nosologies
- Uni-Pharma
- University of Athens
- University of Crete Medical School - University Hospital of Heraklion
- University of Patras
For direct contact, visit the study record on ClinicalTrials.gov .